Clinisys to start its operations in San Francisco

March 14, 2011

Clinisys will start its research and business development at the renowned Mission Bay area of San Francisco, California under the Canadian Technology Accelerator (CTA) program, located at UCSF’s Mission Bay campus. CTA is a program under which Canadian life sciences and technology companies collaborate with the US scientists to increase innovation and commercial endeavors.

The ribbon cutting ceremony, which took place on March 13, 2012, marked the start of this collaborative partnership; the ceremony was presided over by Ed Lee, the Mayor of San Francisco, Canadian Ambassador to the United States Honorable Gary Doer, Regis Kelly, Director of QB3, Cassie Doyle , Consul General of Canada, Douglas Crawford, Associate Director and Mary Anne Koda Kimble, Dean School of Pharmacy at the UCSF, Canadian consulate staff and invited dignitaries from San Francisco.
Clinisys’ placement in the Bay Area was the result of a collaborative partnership between UCFS California Institute for Quantitative Biosciences, or QB3 and The Trade Commissioner Office of the Canadian Consulate in San Francisco and the Canadian Embassy in the United States.

Presence in the Bay area will provide Clinisys researchers the opportunity to be part of the vibrant ecosystem of QB3 and the Silicon Valley.
This is an important landmark for Clinisys and we look forward to be part of the prestigious research community.